John Kottakis

850 total citations
19 papers, 679 citations indexed

About

John Kottakis is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Animal Science and Zoology. According to data from OpenAlex, John Kottakis has authored 19 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 3 papers in Animal Science and Zoology. Recurrent topics in John Kottakis's work include Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (12 papers) and Inhalation and Respiratory Drug Delivery (12 papers). John Kottakis is often cited by papers focused on Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (12 papers) and Inhalation and Respiratory Drug Delivery (12 papers). John Kottakis collaborates with scholars based in United Kingdom, Switzerland and Greece. John Kottakis's co-authors include Giovanni Della Cioppa, Denise Till, Moira H. Thomson, Andrea Rossi, Bernard E. Levine, Lazaros Sichletidis, Alicia Ramírez‐Rivera, G. Rapatz, Vincent Gros and V. Leclerc and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Clinical Therapeutics.

In The Last Decade

John Kottakis

19 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Kottakis United Kingdom 16 644 576 27 20 19 19 679
Denise Till Switzerland 7 571 0.9× 489 0.8× 10 0.4× 21 1.1× 18 0.9× 11 595
Albert Coreno United States 11 324 0.5× 292 0.5× 8 0.3× 8 0.4× 10 0.5× 15 386
F. Di Perna Italy 14 467 0.7× 396 0.7× 16 0.6× 28 1.4× 9 0.5× 21 530
Nancy L. Hordvik United States 10 268 0.4× 176 0.3× 18 0.7× 7 0.3× 8 0.4× 10 306
Rosario Melchor Spain 8 291 0.5× 204 0.4× 35 1.3× 2 0.1× 16 0.8× 16 404
В Е Ноников Russia 3 472 0.7× 401 0.7× 6 0.2× 12 0.6× 6 0.3× 5 494
M. Reza Maleki-Yazdi Canada 11 575 0.9× 464 0.8× 3 0.1× 7 0.3× 13 0.7× 21 610
Sabine Kattenbeck Germany 5 382 0.6× 270 0.5× 2 0.1× 5 0.3× 9 0.5× 10 406
Paolo Noschese Italy 13 188 0.3× 193 0.3× 6 0.2× 22 1.1× 4 0.2× 24 376
Beatriz Seoane Spain 11 387 0.6× 324 0.6× 36 1.3× 16 0.8× 28 480

Countries citing papers authored by John Kottakis

Since Specialization
Citations

This map shows the geographic impact of John Kottakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kottakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kottakis more than expected).

Fields of papers citing papers by John Kottakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Kottakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kottakis. The network helps show where John Kottakis may publish in the future.

Co-authorship network of co-authors of John Kottakis

This figure shows the co-authorship network connecting the top 25 collaborators of John Kottakis. A scholar is included among the top collaborators of John Kottakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Kottakis. John Kottakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Чучалин, А. Г., A I Manjra, Giovanni Della Cioppa, et al.. (2005). Formoterol Delivered via a New Multi-Dose Dry Powder Inhaler (Certihaler ™ ) Is as Effective and Well Tolerated as the Formoterol Dry Powder Inhaler (Aerolizer ® ) in Children with Persistent Asthma. Journal of Aerosol Medicine. 18(1). 63–73. 5 indexed citations
2.
Bronsky, Edwin A., Jay Grossman, Paul Gallo, et al.. (2004). Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults. Current Medical Research and Opinion. 20(2). 131–137. 32 indexed citations
3.
Bouros, Demosthenes, John Kottakis, Vincent Gros, et al.. (2004). Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV1 reversibility. Current Medical Research and Opinion. 20(5). 581–586. 26 indexed citations
4.
5.
Benhamou, D., A. Cuvelier, Vincent Gros, et al.. (2004). FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer® in chronic obstructive pulmonary disease. International Journal of Clinical Practice. 58(5). 457–464. 6 indexed citations
6.
Mitchell, Charles, Christine Jenkins, R Scicchitano, A Rubinfeld, & John Kottakis. (2003). Formoterol (Foradil®) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma. Pulmonary Pharmacology & Therapeutics. 16(5). 299–306. 22 indexed citations
7.
Friedman, Mitchell, Giovanni Della Cioppa, & John Kottakis. (2002). Formoterol Therapy for Chronic Obstructive Pulmonary Disease: A Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(9). 1129–1139. 15 indexed citations
8.
Rossi, Andrea, Bernard E. Levine, Moira H. Thomson, et al.. (2002). Comparison of the Efficacy, Tolerability, and Safety of Formoterol Dry Powder and Oral, Slow-Release Theophylline in the Treatment of COPD. CHEST Journal. 121(4). 1058–1069. 204 indexed citations
9.
10.
Kottakis, John, Giovanni Della Cioppa, Jacques P.H.M. Creemers, et al.. (2002). Faster Onset of Bronchodilation with Formoterol than with Salmeterol in Patients with Stable, Moderate‐Severe Copd: Results of a Randomized, Double‐Blind Clinical Study. Canadian Respiratory Journal. 9(2). 107–115. 42 indexed citations
11.
Pearlman, David S., John Kottakis, Denise Till, & Giovanni Della Cioppa. (2002). Formoterol Delivered via a Dry Powder Inhaler (Aerolizer): Results from Long-term Clinical Trials in Children. Current Medical Research and Opinion. 18(8). 445–455. 15 indexed citations
12.
Kottakis, John, et al.. (2001). CLINICAL EFFICACY WITH FORMOTEROL IN THE ABSENCE OF A RESPONSE TO SALMETEROL: A REVIEW. International Journal of Clinical Practice. 55(7). 476–479. 4 indexed citations
13.
Eliraz, A, Alicia Ramírez‐Rivera, G. Rapatz, et al.. (2001). SIMILAR EFFICACY FOLLOWING FOUR WEEKS TREATMENT OF ASTHMATICS WITH FORMOTEROL 12 μG B.D. DELIVERED BY TWO DIFFERENT DRY POWDER INHALERS: DIFFERENCES IN INHALER HANDLING. International Journal of Clinical Practice. 55(3). 164–170. 19 indexed citations
14.
Benhamou, D., A. Cuvelier, Jean‐François Muir, et al.. (2001). Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil®AerolizerTM) with salbutamol (VentodiskTM). Respiratory Medicine. 95(10). 817–821. 56 indexed citations
15.
D’Urzo, Anthony, María Cristina De Salvo, Alicia Ramírez‐Rivera, et al.. (2001). In Patients With COPD, Treatment With a Combination of Formoterol and Ipratropium Is More Effective Than a Combination of Salbutamol and Ipratropium. CHEST Journal. 119(5). 1347–1356. 86 indexed citations
16.
Eliraz, A, Alicia Ramírez‐Rivera, Pietro Ferranti, et al.. (2001). Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.. PubMed. 55(3). 164–70. 16 indexed citations
17.
Bouros, Demosthenes, John Kottakis, Pascal Pfister, et al.. (1999). Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma. European Respiratory Journal. 14(3). 627–627. 41 indexed citations
18.
Lötvall, Jan, Á. Callejo Mellén, Peter Arvidsson, et al.. (1999). Similar Bronchodilation with Formoterol Delivered by Aerolizer or Turbuhaler. Canadian Respiratory Journal. 6(5). 412–416. 23 indexed citations
19.
Kottakis, John, et al.. (1999). BRONCHODILATORY RESPONSES TO FORMOTEROL, IPRATROPIUM, AND THEIR COMBINATION IN PATIENTS WITH STABLE COPD. International Journal of Clinical Practice. 53(3). 185–188. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denise Till Breakdown of academic impact, for papers by Albert Coreno Breakdown of academic impact, for papers by F. Di Perna Breakdown of academic impact, for papers by Nancy L. Hordvik Breakdown of academic impact, for papers by Rosario Melchor Breakdown of academic impact, for papers by В Е Ноников Breakdown of academic impact, for papers by M. Reza Maleki-Yazdi Breakdown of academic impact, for papers by Sabine Kattenbeck Breakdown of academic impact, for papers by Paolo Noschese Breakdown of academic impact, for papers by Beatriz Seoane
Rankless by CCL
2026